Stay updated with breaking news from Ralf Baron. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Confo Therapeutics today announced the establishment of its Medical Advisory Board (MAB). The MAB will provide external review and strategic advice for the company's clinical development program including
Positive clinical data on the novel non-opioid VR1 antagonist ACD440 presented at IASP pain conferenceAlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer’s dise...